Low serum cholesterol is a biomarker of advanced disease and poor outcomes in myeloproliferative neoplasms. [PDF]
Leiva O +14 more
europepmc +1 more source
The Intricate Dance Between Inflammation and Myeloproliferative Neoplasms: From Origins to Outcomes. [PDF]
Fleischman AG.
europepmc +1 more source
DARS expression in JAK2V617F-positive myeloproliferative neoplasms: immunohistochemical analysis and clinical associations. [PDF]
Arafat AMA +5 more
europepmc +1 more source
Hypoxia-inducible factors contribute to venous thrombosis in a mouse model of myeloproliferative neoplasms. [PDF]
Ghosh S +6 more
europepmc +1 more source
MDM2 inhibitors in myeloid cancers: from basic biology to clinical use in myeloproliferative neoplasms. [PDF]
Al-Ali HK +3 more
europepmc +1 more source
Molecular genetics of chronic neutrophilic leukemia, chronic myelomonocytic leukemia and atypical chronic myeloid leukemia [PDF]
Bing Li, Robert Peter Gale, Zhijian Xiao
core +1 more source
MPN-FIT: a randomized controlled pilot trial of supervised exercise in myeloproliferative neoplasms. [PDF]
Ouellet M +12 more
europepmc +1 more source
Predominant Merkel Cell Polyomavirus DNA Detection in Essential Thrombocythemia within Myeloproliferative Neoplasms. [PDF]
Liu D +7 more
europepmc +1 more source

